[{"id":"40b5aab2-ff74-48ab-bfb2-0f0dc31812ee","acronym":"","url":"https://clinicaltrials.gov/study/NCT03897543","created_at":"2021-01-18T19:11:43.141Z","updated_at":"2024-07-02T16:36:32.746Z","phase":"Phase 1/2","brief_title":"ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma","source_id_and_acronym":"NCT03897543","lead_sponsor":"Abivax S.A.","biomarkers":" AFP","pipe":"","alterations":" ","tags":["AFP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Opdivo (nivolumab) • ABX196"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 08/30/2019","start_date":" 08/30/2019","primary_txt":" Primary completion: 06/30/2021","primary_completion_date":" 06/30/2021","study_txt":" Completion: 06/30/2023","study_completion_date":" 06/30/2023","last_update_posted":"2021-03-26"}]